Product Images Dextroamphetamine Sulfate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Dextroamphetamine Sulfate NDC 45963-304 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image 1
image 10
This text provides the description and usage information for Dextroamphetamine Sulfate Extended-Release Capsules. It includes information on the medication's dosage, storage temperature, manufacturing details, and safety precautions for dispensing. The text also advises pharmacists to dispense the medication guide to patients and provides a website for printing additional guides. The serialization coding area and product lot number are displayed.*
image 2
image 3
image 4
image 5
image 6
image 7
image 8
This medication is Dextroamphetamine Sulfate in extended-release capsules form. Each capsule contains 5 mg of the active ingredient and is designed to release an initial dose promptly, followed by a gradual release over a prolonged period of time. The medication guide should be dispensed to each patient by the pharmacist. The usual dosage should be determined based on the accompanying prescribing information. Safety closures should be used when dispensing this product unless otherwise directed. It should be stored in a tight, light-resistant container at room temperature between 20°C and 25°C. The manufacturer is Teva Pharmaceuticals. Serialization coding area and LOT/EXP number are also present. Print Medication Guides can be obtained from www.tevausa.com/medguides.*
image 9
This is a medication for prescription use with the name Dextroamphetamine Sulfate Extended-Release Capsules. It comes in a bottle with 90 capsules to be dispensed by a pharmacist along with a Medication Guide for patients. The capsules contain 10 my of Dextroamphetamine Sulfate and are prepared to release an initial dose promptly and gradually release the remaining medication over a prolonged period. The normal dosage information is available in the prescribing information. It needs to be stored in a tightly closed, light-resistant container within 68° and 77°F. It is manufactured by Teva Pharmaceuticals and the details on lot number and expiration date are provided. There is a serialization coding area on the bottle. To know more, the Medication Guide can be accessed at www.tevausa.com/medguides.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.